31 results about "Precordial pain" patented technology

Disclosed is a Chinese medicament for treating heart diseases, which is prepared from astragalus root, pilose asiabell root, lilyturf root, prepared rehmannia root, poria with hostwood, dandelion, gypsum, pinellia tuber, thunberg fritillary bulb, baikal skullcap root, bamboo leaves, Chinese angelica root, polygala root, Arisaema cum Bile, cardamom, grassleaved sweetflag rhizome and licorice root.

The invention relates to a Chinese medicinal capsule preparation for treating coronary heart disease. Angina pectoris belongs to the categories of chest blockage, cardiodynia, precordial pain with cold limbs, angina pectoris and the like of the traditional Chinese medicinal science, is usually caused by hemagglutination, deficiency of both qi and yin and the like, and is related to factors such as exciting emotion, overwork, oldness weak body and the like; the clinical characteristic of the angina pectoris is paroxysmal precordial compressing pain; and the pathogenesis is usually a deficiencysyndrome or an excess syndrome, wherein the excess syndrome is qi stagnation, blood stasis, turbid phlegm and obstruction of heart meridians, and the deficiency syndrome is deficiency of yin, yang, qi and blood, abnormal heart vessels, heart yang deficiency and weak beating of the heart meridians, and stagnant blood. Yin exuberance causes cold, so that stagnation of qi and blood and blood stasis in the heart vessels are caused; and the stagnation of qi and blood and the blood stasis in the heart vessels are direct reasons of the attack of the coronary heart disease. According to the characteristics of diseases such as heart yang deficiency, heart qi deficiency, stagnation of the heart blood and the like and a principle that the tangible blood cannot be quickly generated, intangible gas should be urgently fixed and the blood stasis is removed for promoting tissue regeneration, a method for strengthening the body resistance to eliminate pathogenic factors and activating blood circulation to dissipate the blood stasis is adopted, and the preparation actually has a good effect of treating the disease. Through clinical observation, the preparation has remarkable effects of improving the S-T segment of an electrocardiogram and reducing RT wave change. The preparation has whole prescription compatibility, and has good effects of tonifying qi, activating blood circulation, opening orifices and relieving pain. The preparation is specially developed into capsules; and medicines can be absorbed quickly, has quick response and small side effects, can be taken for a long time, is an ideal medicine for clinically treating the coronary heart disease and the angina pectoris, and is also panacea which is difficultly obtained by patients.

The invention discloses gel cream for treating a coronary heart disease and a preparation process and a matrix accessory formula for the gel cream for treating the coronary heart disease. Salvia miltiorrhiza, radix paeoniae rubra, rhizoma chuanxiong, safflower carthamus and dalbergia wood in a prescription are extracted and refined to obtain an extract, and the extract and a proper matrix are prepared into the gel cream, the gel cream is used for treating thoracic obstruction, chest stuffiness and precordial pain which are caused by internal blockage of static blood and cardiovascular diseases such as angina pectoris with the above symptoms. The preparation method comprises extracting essential oil from the dalbergia wood by a water vapor distilling method; extracting the salvia miltiorrhiza, the rhizoma chuanxiong and dregs of the dalvergia wood by 90% of ethanol, and extracting the dregs of the salvia miltiorrhiza, the rhizoma chuanxiong and the dalvergia wood, the radix paeoniae rubra and the safflower carthamus by water; purifying filtrate by macroreticular resin; concentrating the purified liquid medicine into liquid medicine with the relative density of 1.15-1.25 (measured at the temperature of 50 DEG C ), combining the liquid medicine with an ethanol extracted cream, mixing the mixture with the matrix and finally adding the essential oil; and stirring for 20-120 minutes, and coating, pressing and cutting to obtain the refined gel cream for treating the coronary heart disease. Eluent is equal to 40% of ethanol and is four times of the resin, and the elution speed is 3BV / H.

The invention discloses medicament for treating cardiac neurosis and a preparation method of the medicament. The medicament solves the problem that existing medicament is poor in effect on treatment of cardiac neurosis and has side effects. The medicament for treating cardiac neurosis comprises the following main materials of schisandra chinensis, manyprickle acanthopanax roots, albizzia julibrissin durazz, American ginseng, radix polygoni multiflori preparata, magnetit, fungus ganoderma lucidum, angelica sinensis, prepared dried rehmannia, fushen, agarwood and semen ziziphi spinosae. The medicine further comprises the following auxiliary materials of lumbrokinase, polypeptide, multivitamins, water-soluble dietary fibers, acipimox, phosphatidylcholine and honey. The medicament has the good curative effect on common cardiac neurosis in cardiovascular diseases, and has wide application prospect in the fields of treatment of palpitation, precardium area pains, dyspnea, panasthenia, anxiety, sinus arrhythmia and the like.

The invention provides medicine for treating coronary heart disease. The medicine comprises red ginseng, cassia twig, evodia, acorus tatarinowii, angelica sinensis, astragalus mongholicus, fructus choerospondiatis, semen ziziphi spinosae, sanders, dalbergia odorifera, ganoderma lucidum, prepared aconite root, rhizoma chuanxiong and prepared radix licorice. The components of the medicine are matched to warm yang and remove blood stasis and tonify the heart and soothe the nerves, and the medicine has evident curative effect on coronary heart disease, angina, myocardial ischemia, cardiac insufficiency (heart failure), vascular disease, cerebral arteriosclerosis and the like. The medicine is applicable to chest distress and palpitation, breath shortness and weakness, dyspnea, precordial pain, facial paralysis, unsmooth speech, limb inconvenience, memory deterioration, vascular intimal injury, heart and cerebral ischemia and hypoxia caused by thrombosis, heart function descent, brain infarction and the like. Clinical tests show that the medicine is quite good in coronary heart disease curative effect.

The invention discloses an externally-used analgesic medicinal composition. The externally-used analgesic medicinal composition comprises the following components: toad venom, scorpio, ligusticum wallichii, trogopterus dung, resina liquidamberis, radix curcumae and turmeric. Through combination of the toad venom and the scorpio with strong analgesic effects, the externally-used analgesic medicinal composition can be used for treating patients suffering from severe pains; in coordination with the Chinese herbs, namely the trogopterus dung, the resina liquidamberis, the radix curcumae and the turmeric, which are used for treating traumatic injuries, snake bites, insect bites, stabbing chest pains, and precordial pains with chest discomfort, the externally-used analgesic medicinal composition can be used for treating different pains; with the assistance of the ligusticum wallichii, the externally-used analgesic medicinal composition can activate blood circulation, remove stasis and dredge veins. Therefore, the externally-used analgesic medicinal composition provided by the invention has a significant therapeutic effect on the paints.

The invention discloses a medicine for treating viral myocarditis and a preparation method and belongs to the field of traditional Chinese medicine. The medicine comprises the following active ingredients: a pig bone, folia perillae acutae, gardenia, mother-of-pearl, herba aristolochiae, turnip, polygala tenuifolia, a creeping fig root, allium macrostemon, glabrous sarcandra herb, siegesbeckia orientalis, crepis phoenix, acalypha australis, sangusis draconis, lantana camara and lepisorus thunbergianus. Medicinal materials chosen by the medicine are appropriate in compatibility, and the medicine corresponds with theories of traditional Chinese medicine and modern medicine and pharmacology and has effects of tonifying qi, enriching blood, nourishing yin, clearing away heat, nourishing a heart, soothing nerves, diminishing swelling and alleviating pain. The medicine has a significant curative effect on symptoms such as palpitation, short breath, arrhythmia, chest distress, hypodynamia, spontaneous perspiration, fatigue and precordial pain caused by myocarditis, is short in treatment course, takes effect quickly, avoids recurrence after curing, is safe and reliable, has no toxic or side effects, can achieve the purpose of treating both principal and secondary aspects of a disease, has a miraculous effect and is practical and worthy of wide popularization and application clinically.

The invention belongs to the field of medicines, and provides a compound preparation for mainly treating coronary heart disease and a preparation method thereof, the compound preparation for treatingcoronary heart disease comprises the following components in parts by weight: 7-19 parts of motherwort, 6-15 parts of sea-buckthorn leaves, 3-13 parts of ligusticum wallichii, 4-16 parts of hyssopus officinalis, 10-20 parts of Ziziphora bungeana and 8-17 parts of radix paeoniae rubra. The compound preparation has the functions of promoting blood circulation to remove meridian obstruction, removingblood stasis to promote tissue regeneration and clearing away the heart-fire to relieve restlessness through the reasonable proportion and synergistic effect of motherwort, sea-buckthorn leaves, ligusticum wallichii, hyssopus officinalis, Ziziphora bungeana and radix paeoniae rubra, is mainly used for treating diseases such as precordial pain, palpitation, chest distress and shortness of breath,the curative effect is obvious, no toxic and side effect is generated, and the product is high in safety.

The invention discloses a drug for treating vital myocarditis, and the drug is prepared from the following raw materials in parts by weight: 10-15 parts of radix isatidis, 8-12 parts of folium isatidis, 2-6 parts of ginseng, 6-10 parts of radix salviae miltiorrhizae, 8-12 parts of radix astragali, 2-3 parts of honeysuckle flowers, 2-4 parts of pseudo-ginseng, 3-6 parts of poria with hostwood, 5-13 parts of platycladi seeds, 5-13 parts of radix asparagi, 4-8 parts of leeches, 2-4 parts of rhizoma ligustici wallichii, 5-13 parts of fructus schizandrae, 3-12 parts of liquorice, 3-6 parts of polygala tenuifolia and 1-2 parts of cinnabar and also contains cinnamaldehyde, creatinine, a vitamin C, coenzyme Q10, and the like. The drug disclosed by the invention combines the traditional and Western medicine, can be used for treating both symptoms and root causes, has the effects of diminishing inflammation and resisting viruses, tonifying Qi and replenishing blood, nourishing yin and clearing heat, nourishing heart and calming nerves, eliminating evil and strengthening healthy energy and can be used for treating palpitation, short breath, heart meridian disorder, chest distress, asthenia, spontaneous perspiration, limb and mind fatigue, precordial pain, severe palpitation and intermittent pulse. After the drug disclosed by the invention is taken by a patient, an ideal treatment effect is achieved, and the myocarditis symptoms are obviously improved or eliminated.

The invention relates to a medicinal oral preparation of musk drop pill with the functions of arousing coma, relieving pain and treating precordial pain, chest pain, the drop pill has the advantages of high biological availability, quick-speed medicine release, quick-speed effect, less toxic and side effects, higher medicinal content, smaller amount of administration, accurate administration dosage, easy administering, low price, and facilitated carrying. The medicine is prepared through the conventional drop pill preparing process.

The invention discloses a malaytea scurfpea fruit Chinese medicinal oral liquid for treating senile anemia. The malaytea scurfpea fruit Chinese medicinal oral liquid is prepared from the following bulk pharmaceuticals in parts by weight: 100-230 parts of malaytea scurfpea fruit, 100-230 parts of Chinese angelica, 100-230 parts of sealwort, 100-230 parts of suberect spatholobus stem, 100-230 parts of Chinese magnoliavine fruit and 100-230 parts of prepared multiflower knotweed tuber. The oral liquid disclosed by the invention can be used for eliminating simultaneous dizziness, precordial pain, insanity, idleness, indifference, moodiness, temperament, hallucination and the like caused by senile anemia, can be used for improving anemia symptoms, has a remarkable curative effect, and is worthy of clinical popularization and application.

The invention discloses a traditional Chinese medicine compound composition with the effect of treating precordial pain with chest discomfort, a preparation method and application thereof. The composition is prepared from 12 to 36 parts of codonopsis pilosula, 12 to 36 parts of astragalus membranaceus, 9 to 27 parts of ophiopogon japonicus, 9 to 27 parts of polygonatum odoratum, 9 to 27 parts of curcuma zedoaria, 12 to 36 parts of salvia miltiorrhiza, 9 to 27 parts of paeonia suffruticosa, 6 to 18 parts of zantedeschia aethiopica spreng, 9 to 27 parts of ziziphus jujube, and 6 to 18 parts of schisandra chinensis. The composition has the advantages that matching optimizing composition is performed through a theory of syndrome differentiation and treatment, the drugs are combined to achievethe efficacies of promoting blood circulation to remove meridian obstruction, and removing cardiopyrexia for tranquilization. Clinical experiment results show that the composition has obvious efficacies of treating precordial pain with chest discomfort, protecting the heart and recovering the cardiac function, and is safe in clinical medication.

The invention discloses a health wine for preventing and treating atherosclerosis, prepared from the materials according to following parts by weight per liter of the health wine: 10-20 g of Pinus massoniana needles, 15-30 g of Caulis et Folium Gynostemmatis Pentaphylli, 9-15 g of Fructus Trichosanthis, 3-10 g of Rhizoma Curcumae Longae, 6-12 g of Radix Polygoni Multiflori Preparata, and 3-12 g of Fructus Lycii. The health wine has the effects of replenishing qi to invigorate the spleen, nourishing liver and kidney, and dissipating phlegm and removing blood stasis, and has the special functions of resisting arteriosclerosis, lowering blood lipid, resisting oxidation, resisting coagulation, resisting inflammation, clearing free radicals, preventing aging, controlling cancers, enhancing immunity, lowering blood glucose, lowering blood pressure and the like. The health wine of the invention has significant effect in treating atherosclerosis with symptoms, such as dizziness, headache, limb numbness, palpitation, chest distress, shortness of breath, unsmooth speech, hemiplegia, neck discomfort, precordial pain, lower limb limping, red tongue with petechiae at edge, thick white greasy coating, and thready, unsmooth, wiry and slippery pulses.

The invention discloses a Chinese medicinal preparation for treating chronic pancreatitis with a wetness-heat of liver and gallbladder syndrome. Chronic pancreatitis, belonging to the fields of 'stomachache', 'splenic precordial pain' and the like in traditional Chinese medicine, and the pathogenesis is mainly caused by damages to spleen and stomach by improper diet, preference to fat, sweet and spicy foods, and the like as well as endogenesis of wet heat, heat induced by long-term depression, blockage of damp and heat and stagnation of qi and blood. By means of Chinese traditional treatment, the effects of eliminating dampness and heat, clearing liver and benefiting bile can be achieved. A decoction is prepared from the Chinese medicinal materials of adiantum soboliferum, Japanese claw fern herb, Chinese neillia root, humulus scandens, mile swertia, largeflower jasmine flower, bauhinia seed, silk tree flower, isodon amethystoides and corn stigma. As proved by clinical test, the Chinese medicinal preparation is 84.9 percent in total effective rate, being remarkably superior to the total effective rate of 69.7 percent of a control group, and is free from toxic and side effects.

The invention discloses a health wine for preventing and treating atherosclerosis, prepared from the materials according to following parts by weight per liter of the health wine: 10-20 g of Pinus massoniana needles, 15-30 g of Caulis et Folium Gynostemmatis Pentaphylli, 9-15 g of Fructus Trichosanthis, 3-10 g of Rhizoma Curcumae Longae, 6-12 g of Radix Polygoni Multiflori Preparata, and 3-12 g of Fructus Lycii. The health wine has the effects of replenishing qi to invigorate the spleen, nourishing liver and kidney, and dissipating phlegm and removing blood stasis, and has the special functions of resisting arteriosclerosis, lowering blood lipid, resisting oxidation, resisting coagulation, resisting inflammation, clearing free radicals, preventing aging, controlling cancers, enhancing immunity, lowering blood glucose, lowering blood pressure and the like. The health wine of the invention has significant effect in treating atherosclerosis with symptoms, such as dizziness, headache, limb numbness, palpitation, chest distress, shortness of breath, unsmooth speech, hemiplegia, neck discomfort, precordial pain, lower limb limping, red tongue with petechiae at edge, thick white greasy coating, and thready, unsmooth, wiry and slippery pulses.

The invention belongs to the technical field of traditional Chinese medicines and aims to provide a traditional Chinese medicine composition which can be used for effectively treating precordial pain aiming at the pathogenic mechanism of precordial pain caused by yang deficiency and combining with specific physical conditions of middle-aged and aged people. The traditional Chinese medicine composition is prepared by combining the following raw medicines in parts by weight: 3-6 parts of liquorice, 6-9 parts of dried gingers, 8-12 parts of cassia twig, 15-25 parts of monkshood, 9-15 parts of jave amonum fruit, 8-12 parts of cinnamon, 8-12 parts of epimedium herb, 3-6 parts of coptis root, 3-6 parts of Chinese angelica, 0.1-0.5 part of gleditsia sinensis, 8-12 parts of radix astragali, 8-12 parts of Indian bread and 8-12 parts of officinal magnolia bark. The traditional Chinese medicine composition selects common medicines but can gain satisfactory treatment effects by dialectically analyzing the disease accurately, carrying out reasonable compatibility on the conventional medicines and taking the dosage into account.

The invention discloses a traditional Chinese medicine composition for treating coronary heart disease. The traditional Chinese medicine composition is prepared from, by weight, 10-15 parts of semen boitae, 4-6 parts of aizoon stonecrop herb, 2-4 parts of Yunnan rhodiola, 6-8 parts of radix seu spiranthis lanceae, 4-5 parts of rose rhodobryum herb, 2-4 parts of pubescent holly root, 6-8 parts of herba cynomorii, 10-12 parts of walnut shell, 6-8 parts of wedelia chinensis, 6-10 parts of Japanese banana flower, 2-4 parts of parched fructus aurantii, 4-5 parts of rhus javanica, 2-4 parts of rhizoma alismatis, 6-8 parts of semen plantaginis, 4-5 parts of fiveleaf akebia fruit, 12-15 parts of honey-fried licorice root, 5-6 parts of vinegar processed rhizoma corydalis, 2-4 parts of peanut shell, 6-7 parts of potato flower, 8-12 parts of cherry nut and 5-7 parts of trogopterus dung. Scientific compatibility of pure natural herbal medicines is realized, and no toxic or side effect is caused; through combination of different medicinal materials and synergism of effective components of the medicinal materials, the functions of promoting blood circulation to remove blood stasis, reinforcing qi and nourishing blood, inducing diuresis to alleviate edema, warming yang and dispersing blood stasis, and tonifying heart to soothe the nerves are realized, chest distress and palpitation, short of breath, weakness, dyspnea, precordial pain and other symptoms caused by coronary heart disease can be effectively treated and relieved.

The invention discloses a Chinese herba preparation for treating chronic pancreatitis. According to traditional Chinese medicine, the chronic pancreatitis belongs to the category of stomachache, splenic precordial pain, diarrhea and the like. Damp-heat, Qi stagnation, blood stasis and phlegm accumulation are generated by the discord of the spleen and the liver and weakness of the spleen and the stomach, and as a result, durability inflammatory lesion occurs to pancreas. For this purpose, traditional Chinese medicine cynanchum thesioides, bitter bamboo leaves, cassia nomame, ginseng fruit, common hawksbeard, lespedeza cuneata G. Don, atractylodes, arundina graminifolia, haloragis micrantha, prunella vulgaris, black pepper and liquorice are selected, and decocted with water into decoction. Clinical tests show that the total effective rate reaches 97.5%, and the curative effect is remarkable.

The invention belongs to the technical field of traditional Chinese medicines and aims to provide a traditional Chinese medicine composition which can be used for effectively treating precordial pain aiming at the pathogenic mechanism of precordial pain caused by yang deficiency and combining with specific physical conditions of middle-aged and aged people. The traditional Chinese medicine composition is prepared by combining the following raw medicines in parts by weight: 3-6 parts of liquorice, 6-9 parts of dried gingers, 8-12 parts of cassia twig, 15-25 parts of monkshood, 9-15 parts of jave amonum fruit, 8-12 parts of cinnamon, 8-12 parts of epimedium herb, 3-6 parts of coptis root, 3-6 parts of Chinese angelica, 0.1-0.5 part of gleditsia sinensis, 8-12 parts of radix astragali, 8-12 parts of Indian bread and 8-12 parts of officinal magnolia bark. The traditional Chinese medicine composition selects common medicines but can gain satisfactory treatment effects by dialectically analyzing the disease accurately, carrying out reasonable compatibility on the conventional medicines and taking the dosage into account.

The Chinese medicine capsule preparation Naoxin'an for curing hemiparalysis from apoplexy, obstruction of qi in the chest and precordial pain is made of 19 Chinese medicinal materials of astragalus root, carthamus flower, notoginseng root, pueraria root, ligusticum root and others. Said invention is high in cure rate, short in course of treatment and has no side effect.

Disclosed is a Chinese medicament for treating heart diseases, which is prepared from astragalus root, pilose asiabell root, lilyturf root, prepared rehmannia root, poria with hostwood, dandelion, gypsum, pinellia tuber, thunberg fritillary bulb, baikal skullcap root, bamboo leaves, Chinese angelica root, polygala root, Arisaema cum Bile, cardamom, grassleaved sweetflag rhizome and licorice root.

The invention belongs to the field of traditional Chinese medicines, and relates to a traditional Chinese medicine for treating viral myocarditis. The traditional Chinese medicine for treating viral myocarditis comprises rhodiola rosea, caulis dendrobii, fructus hordei germinatus, cortex albizziae, poria pararadicis, herba taraxaci, radix platycodi, fructus arctii, rhizoma notopterygii, ramulus mori, rhizoma alismatis, rhizoma arisaematis cum bile, cortex magnoliae officinalis, rhizoma acori tatarinowii and talcum. The traditional Chinese medicine for treating viral myocarditis has effects oftonifying qi, nourishing blood, nourishing yin, clearing heat, tranquilizing the mind by nourishing the heart, eliminating pathogen and strengthening vital qi, and can be used for treating myocarditis-induced palpitations and shortness of breath, cardiac arrhythmia, chest tightness and fatigue, spontaneous perspiration, vexation causing sleeplessness, memory trance, body and mental weariness, dizziness, tinnitus, amaurosis syncope, precordial pain, severe palpitation and intermittent pulse.

The invention relates to the field of pharmaceutical formulation, and particularly relates to a medicament for the treatment of viral myocarditis. The medicament is characterized by being prepared from the following herbal materials in parts by weight: 30-50 parts of herba rabdosiae, 5-10 parts of ligularia japonica, 10-20 parts of clinopodium polycephalum, 10-20 parts of herba Dracocephali Integrifolii, 10-20 parts of barks of tangut barberry, 10-30 parts of rhodobryum roseum, 20-40 parts of inula flower, 10-20 parts of uncaria rhynchophylla, 5-25 parts of radix arnebiae seu lithospermi, 5-25 parts of fructus citri, 5-20 parts of radix curcumae, 5-20 parts of loofah sponge, 5-20 parts of alpine swertia, 5-20 parts of caragana korshinskii roots, 5-25 parts of artemisia capillaris, and 10-30 parts of witch hazel; and the sixteen herbal materials above are soaked in water, after the obtained object is decocted, residues are removed, and then filtrate is obtained. The medicament disclosed by the invention has the effects of tonifying Qi, replenishing blood, nourishing yin and clearing heat, tranquilizing mind by nourishing the heart, and relieving swelling and pain, and has a significant curative effect on symptoms such as palpitation, shortness of breath, heart vessel aberration, chest distress, lacking in strength, spontaneous perspiration, limb weakness, spiritlessness, precordial pain, and the like.

The invention belongs to the technical field of traditional Chinese medicine and relates to a compound traditional Chinese medicine preparation for treating precordial pain with chest discomfort. The principles of treating coronary heart disease (chest discomfort) are followed in the invention: invigorating qi and resolving phlegm, tonifying Qi and promoting circulation of qi, and strengthening body resistance and eliminating evil. Astragalus membranaceus, trichosanthes kirilowii maxim, allium macrostemon and pinellia ternata are used as main herbs, and are combined with auxiliary herbs to prepare the compound traditional Chinese medicine preparation, a medicated thread (medicated thread for invigorating qi and resolving phlegm) of the compound traditional Chinese medicine preparation is prepared in combination with acupuncture point circulation therapy, continuous retaining needle experiments for treating the precordial pain with chest discomfort are carried out on shanzhong and xinshupoint, and results indicate that the medicated thread (medicated thread for invigorating qi and resolving phlegm) of the compound traditional Chinese medicine preparation can be used for effectively reducing the precordial pain with chest discomfort, the action is better than that of nitrate drugs, the compound traditional Chinese medicine preparation can be used for treating the precordial pain with chest discomfort, and the application prospect is good.

The invention relates to a Chinese medicinal capsule preparation for treating coronary heart disease. Angina pectoris belongs to the categories of chest blockage, cardiodynia, precordial pain with cold limbs, angina pectoris and the like of the traditional Chinese medicinal science, is usually caused by hemagglutination, deficiency of both qi and yin and the like, and is related to factors such as exciting emotion, overwork, oldness weak body and the like; the clinical characteristic of the angina pectoris is paroxysmal precordial compressing pain; and the pathogenesis is usually a deficiencysyndrome or an excess syndrome, wherein the excess syndrome is qi stagnation, blood stasis, turbid phlegm and obstruction of heart meridians, and the deficiency syndrome is deficiency of yin, yang, qi and blood, abnormal heart vessels, heart yang deficiency and weak beating of the heart meridians, and stagnant blood. Yin exuberance causes cold, so that stagnation of qi and blood and blood stasis in the heart vessels are caused; and the stagnation of qi and blood and the blood stasis in the heart vessels are direct reasons of the attack of the coronary heart disease. According to the characteristics of diseases such as heart yang deficiency, heart qi deficiency, stagnation of the heart blood and the like and a principle that the tangible blood cannot be quickly generated, intangible gas should be urgently fixed and the blood stasis is removed for promoting tissue regeneration, a method for strengthening the body resistance to eliminate pathogenic factors and activating blood circulation to dissipate the blood stasis is adopted, and the preparation actually has a good effect of treating the disease. Through clinical observation, the preparation has remarkable effects of improving the S-T segment of an electrocardiogram and reducing RT wave change. The preparation has whole prescription compatibility, and has good effects of tonifying qi, activating blood circulation, opening orifices and relieving pain. The preparation is specially developed into capsules; and medicines can be absorbed quickly, has quick response and small side effects, can be taken for a long time, is an ideal medicine for clinically treating the coronary heart disease and the angina pectoris, and is also panacea which is difficultly obtained by patients.

The invention discloses traditional Chinese medicine pills for treating cardioneurosis. The traditional Chinese medicine pills are prepared through double-screw mixing, extruding and granulating processes and composed of, by weight, 25-35 parts of ginseng, 20-30 parts of pueraria lobata, 20-25 parts of pilos antler, 8-10 parts of pseudo-ginseng, 6-8 parts of radix polygonati officinalis and 4-8 parts of endothelium corneum gigeriae galli. Ginseng, pueraria lobata and pilos antler have functions of treating palpitation, precordial pain, chest distress, shortness of breath and difficult breathing caused by cardioneurosis; radix polygonati officinalis and endothelium corneum gigeriae galli have functions of dizziness, insomnia and dreaminess; traditional Chinese medicine for treating cardioneurosis is made into pills, so that the pills are portable, can be taken at any time and is comparatively convenient and safe.

The present invention relates to a pharmaceutical process of saffron multiple glycoside and its tablet. Said pharmaceutical process includes the following steps: treating raw material, defatting with organic solvent, aqueous ethyl alcohol extraction and spray-drying, and its tablet-making process includes the following steps: adding auxiliary material, granulating, tabletting and coating so as to obtain the invented product for curing precordial pain due to obstruction of qi in the chest. Its production process is simple, and high in yield.

A traditional Chinese medicine comprising Baifu Tablets, comprising: 60-100 parts of Baifu Tablets; 20-30 parts of Angelica Sinensis; 15-25 parts of Yuanshen; ; Atractylodes macrocephala 35-40; sucrose 70-80; micro-silica gel 4-6; using Baifu tablets, dried ginger, etc. as raw materials, does not contain hormones and antibiotics in western medicine, and will not produce drug resistance; No obvious side effects were found in the research. It is safe, easy to absorb, quick to take effect, and convenient to use; the finished product has the functions of restoring yang and rescuing adverse events, replenishing fire and supporting yang, dispelling cold and relieving pain, and is used for yang collapse, cold limbs and pulse Slight, heart yang deficiency, chest pain and heart pain, deficiency cold vomiting and diarrhea, abdominal cold pain, kidney yang deficiency, impotence and uterine cold, yin cold edema, yang deficiency exogenous, cold damp arthralgia; low cost, simple process, can be widely used .